NCT06626373

Brief Summary

The objective of this human study is to determine if the metabolic benefits observed with other anthocyanin-rich berries extend to elderberries. To accomplish this, we performed a short-term controlled feeding study in overweight but healthy volunteers in a placebo-controlled crossover clinical trial. Major study endpoints included blood glucose and insulin response to a high-carbohydrate meal challenge, indirect calorimetry, and profiling of the fecal microbiome.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 27, 2023

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 10, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 10, 2024

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

October 1, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 3, 2024

Completed
Last Updated

October 3, 2024

Status Verified

October 1, 2024

Enrollment Period

1.2 years

First QC Date

October 1, 2024

Last Update Submit

October 1, 2024

Conditions

Keywords

ObesityElderberry

Outcome Measures

Primary Outcomes (3)

  • Substrate oxidation

    Participants will be monitored by a metabolic cart at rest and while walking

    3.5 hours

  • Glucose tolerance/insulin sensitivity

    Blood will be collected following a meal tolerance test

    3 hours

  • Gut Microbiome analysis

    Feces will be collected before and after the intervention

    5 minutes

Study Arms (2)

Experimental: Elderberry Juice

EXPERIMENTAL

Participants will consume elderberry juice twice/day for 1-week as well as our provided diet for 4 days.

Other: Elderberry Juice

Placebo Comparator: Placebo beverage

PLACEBO COMPARATOR

Participants will consume placebo beverage twice/day for 1-week as well as our provided diet for 4 days.

Other: Placebo Beverage

Interventions

Participants will consume elderberry juice 1-week.

Experimental: Elderberry Juice

Participants will consume placebo beverage twice/day for 1-week.

Placebo Comparator: Placebo beverage

Eligibility Criteria

Age22 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women and Men between 22 and 75 years of age with a body mass index of 25 kg/m2 or above

You may not qualify if:

  • Pregnant or trying to become pregnant
  • Have a body mass index less than 25 kg/m2
  • Are younger than 22 years of age, or older than 75 years of age
  • Known allergy or intolerance to elderberries
  • History of bariatric surgery or nutrient malabsorption disease (such as celiac disease) or other metabolic disorders requiring a special diet that is not in accord with the diet behavior requested for this study
  • Adherence to restrictive (vegetarian or vegan) or extreme (fad \[ex. Ketogenic or Atkins\] or quick weight loss/gain) diet patterns and unwillingness to consume a conventional, omnivorous diet and maintain body weight
  • Habitual use of tobacco (including vaping) products in the last 6 months
  • Diagnosis or treatment of cancer in the past 3 years
  • Crohn's disease or diverticulitis
  • Suspected or known strictures, fistulas or physiological/mechanical GI obstruction
  • Use of certain medications (prescription or over-the-counter) that may interfere with the study objectives, including blood thinning medications
  • Type 2 diabetes requiring the use of medication
  • Fasting blood glucose \> 125 mg/dL
  • Unable or unwilling to give informed consent or communicate with study staff
  • Other medical, psychiatric, or behavioral factors that in the judgment of the Principal Investigator may interfere with study participation or the ability to follow the intervention protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Washington State University

Spokane, Washington, 99202, United States

Location

Related Publications (2)

  • Minj J, Riordan J, Teets C, Fernholz-Hartman H, Tanggono A, Lee Y, Chauvin T, Carbonero F, Solverson P. Diet-Induced Rodent Obesity Is Prevented and the Fecal Microbiome Is Improved with Elderberry (Sambucus nigra ssp. canadensis) Juice Powder. J Agric Food Chem. 2024 Jun 5;72(22):12555-12565. doi: 10.1021/acs.jafc.4c01211. Epub 2024 May 22.

    PMID: 38776153BACKGROUND
  • Rust BM, Riordan JO, Carbonero FG, Solverson PM. One-Week Elderberry Juice Treatment Increases Carbohydrate Oxidation after a Meal Tolerance Test and Is Well Tolerated in Adults: A Randomized Controlled Pilot Study. Nutrients. 2023 Apr 25;15(9):2072. doi: 10.3390/nu15092072.

    PMID: 37432227BACKGROUND

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Double (ParticipantOutcomes Assessor)
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 1, 2024

First Posted

October 3, 2024

Study Start

February 27, 2023

Primary Completion

May 10, 2024

Study Completion

May 10, 2024

Last Updated

October 3, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations